Skip to main content
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: Free Radic Biol Med. 2008 Jun 27;45(7):994–1001. doi: 10.1016/j.freeradbiomed.2008.06.017

Table 2.

Electrochemical HPLC detection of BH4, BH2 and ascorbate in adult rat cardiomyocytes supplemented with ascorbate and BH4.

Treatment BH4 (pmol/mg protein) BH2 (pmol/mg protein) Ascorbate (pmol/mg protein)
Control 0.066±0.058 0.0 14.55±0.65
Asc/BH4 1.33±0.71a 104.4±47.6 801.0±315.3a
Asc/BH4 + LPS 0.297±0.092b 172.66±54.3 501.9±58.5
Asc/BH4 + TNF-α + IFN-γ 0.609±0.138b 196.0±21.8 814.0±124.2

Adult cardiomyocytes were pre-treated with ascorbate and BH4 for 6 hr before addition of LPS and cytokines for 12 hr. Conditions include: LPS (1μg/ml); TNF-α (20 ng/ml); IFN-γ (50 ng/ml); ascorbate (75 μM)/BH4 (10 μM). Values represent the mean±SD of at least 3 experiments.

a

P<0.01 vs control;

b

P<0.05 vs Asc/BH4.

HHS Vulnerability Disclosure